<i>ETV6</i> mutations in early immature human T cell leukemias

Pieter Van Vlierberghe(Columbia University Irving Medical Center), Alberto Ambesi‐Impiombato(Columbia University Irving Medical Center), Arianne Pérez-García(Columbia University Irving Medical Center), J. Erika Haydu(Columbia University Irving Medical Center), Isaura Rigo(Columbia University Irving Medical Center), Michael Hadler(Columbia University Irving Medical Center), Valeria Tosello(Columbia University Irving Medical Center), Giusy Della Gatta(Columbia University Irving Medical Center), Elisabeth Paietta(Montefiore Medical Center), Janis Racevskis(Montefiore Medical Center), Peter H. Wiernik(Montefiore Medical Center), Selina M. Luger(University of Pennsylvania), Jacob M. Rowe(Rambam Health Care Campus), Montserrat Rué(Universitat de Lleida), Adolfo A. Ferrando(Columbia University Irving Medical Center)
The Journal of Experimental Medicine
December 12, 2011
Cited by 211Open Access
Full Text

Abstract

Early immature T cell acute lymphoblastic leukemias (T-ALLs) account for ~5-10% of pediatric T-ALLs and are associated with poor prognosis. However, the genetic defects that drive the biology of these tumors remain largely unknown. In this study, analysis of microarray gene expression signatures in adult T-ALL demonstrated a high prevalence of early immature leukemias and revealed a close relationship between these tumors and myeloid leukemias. Many adult immature T-ALLs harbored mutations in myeloid-specific oncogenes and tumor suppressors including IDH1, IDH2, DNMT3A, FLT3, and NRAS. Moreover, we identified ETV6 mutations as a novel genetic lesion uniquely present in immature adult T-ALL. Our results demonstrate that early immature adult T-ALL represents a heterogeneous category of leukemias characterized by the presence of overlapping myeloid and T-ALL characteristics, and highlight the potential role of ETV6 mutations in these tumors.


Related Papers